Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

10.1186/s12878-015-0028-2

Saved in:

Bibliographic Details
Main Authors:	Ong, S.-Y, Truong, H.-T.-T, Diong, C.P, Linn, Y.-C, Ho, A.Y.-L, Goh, Y.-T, Hwang, W.Y.-K
Other Authors:	DUKE-NUS MEDICAL SCHOOL
Format:	Article
Published:	2020
Subjects:	aciclovir calcineurin inhibitor cotrimoxazole cytomegalovirus antigen pp65 foscarnet itraconazole posaconazole thymocyte antibody valaciclovir valganciclovir acute lymphoblastic leukemia acute myeloid leukemia adolescent adult age distribution aged Article blood toxicity controlled study creatinine blood level cytomegalovirus infection drug efficacy drug megadose drug monitoring drug safety female graft versus host reaction hematopoietic stem cell transplantation herpes zoster human human cell immunosuppressive treatment major clinical study male mycosis myelodysplastic syndrome nephrotoxicity neutropenic enterocolitis nonhodgkin lymphoma Pneumocystis pneumonia recurrent virus infection retrospective study risk benefit analysis treatment duration viral clearance virus load virus reactivation
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180347
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-180347
record_format	dspace
spelling	sg-nus-scholar.10635-1803472021-01-08T04:00:51Z Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation Ong, S.-Y Truong, H.-T.-T Diong, C.P Linn, Y.-C Ho, A.Y.-L Goh, Y.-T Hwang, W.Y.-K DUKE-NUS MEDICAL SCHOOL aciclovir calcineurin inhibitor cotrimoxazole cytomegalovirus antigen pp65 foscarnet itraconazole posaconazole thymocyte antibody valaciclovir valganciclovir acute lymphoblastic leukemia acute myeloid leukemia adolescent adult age distribution aged Article blood toxicity controlled study creatinine blood level cytomegalovirus infection drug efficacy drug megadose drug monitoring drug safety female graft versus host reaction hematopoietic stem cell transplantation herpes zoster human human cell immunosuppressive treatment major clinical study male mycosis myelodysplastic syndrome nephrotoxicity neutropenic enterocolitis nonhodgkin lymphoma Pneumocystis pneumonia recurrent virus infection retrospective study risk benefit analysis treatment duration viral clearance virus load virus reactivation 10.1186/s12878-015-0028-2 BMC Hematology 15 1 8 2020-10-26T08:31:18Z 2020-10-26T08:31:18Z 2015 Article Ong, S.-Y, Truong, H.-T.-T, Diong, C.P, Linn, Y.-C, Ho, A.Y.-L, Goh, Y.-T, Hwang, W.Y.-K (2015). Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation. BMC Hematology 15 (1) : 8. ScholarBank@NUS Repository. https://doi.org/10.1186/s12878-015-0028-2 20521839 https://scholarbank.nus.edu.sg/handle/10635/180347 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	aciclovir calcineurin inhibitor cotrimoxazole cytomegalovirus antigen pp65 foscarnet itraconazole posaconazole thymocyte antibody valaciclovir valganciclovir acute lymphoblastic leukemia acute myeloid leukemia adolescent adult age distribution aged Article blood toxicity controlled study creatinine blood level cytomegalovirus infection drug efficacy drug megadose drug monitoring drug safety female graft versus host reaction hematopoietic stem cell transplantation herpes zoster human human cell immunosuppressive treatment major clinical study male mycosis myelodysplastic syndrome nephrotoxicity neutropenic enterocolitis nonhodgkin lymphoma Pneumocystis pneumonia recurrent virus infection retrospective study risk benefit analysis treatment duration viral clearance virus load virus reactivation
spellingShingle	aciclovir calcineurin inhibitor cotrimoxazole cytomegalovirus antigen pp65 foscarnet itraconazole posaconazole thymocyte antibody valaciclovir valganciclovir acute lymphoblastic leukemia acute myeloid leukemia adolescent adult age distribution aged Article blood toxicity controlled study creatinine blood level cytomegalovirus infection drug efficacy drug megadose drug monitoring drug safety female graft versus host reaction hematopoietic stem cell transplantation herpes zoster human human cell immunosuppressive treatment major clinical study male mycosis myelodysplastic syndrome nephrotoxicity neutropenic enterocolitis nonhodgkin lymphoma Pneumocystis pneumonia recurrent virus infection retrospective study risk benefit analysis treatment duration viral clearance virus load virus reactivation Ong, S.-Y Truong, H.-T.-T Diong, C.P Linn, Y.-C Ho, A.Y.-L Goh, Y.-T Hwang, W.Y.-K Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
description	10.1186/s12878-015-0028-2
author2	DUKE-NUS MEDICAL SCHOOL
author_facet	DUKE-NUS MEDICAL SCHOOL Ong, S.-Y Truong, H.-T.-T Diong, C.P Linn, Y.-C Ho, A.Y.-L Goh, Y.-T Hwang, W.Y.-K
format	Article
author	Ong, S.-Y Truong, H.-T.-T Diong, C.P Linn, Y.-C Ho, A.Y.-L Goh, Y.-T Hwang, W.Y.-K
author_sort	Ong, S.-Y
title	Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
title_short	Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
title_full	Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
title_fullStr	Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
title_full_unstemmed	Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
title_sort	use of valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/180347
_version_	1688754036985036800

Use of Valacyclovir for the treatment of cytomegalovirus antigenemia after hematopoietic stem cell transplantation

Similar Items